Evidence map›Paper›PMID 34200750›Full record

ArticleJournal of clinical medicine2021

Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data.

Daniel Dacosta-Sánchez, Carmen Díaz-Batanero, Fermin Fernandez-Calderon, Óscar M Lozano

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Daniel Dacosta-SánchezDepartment of Experimental and Clinical Psychology, University of Huelva, 21071 Huelva, Spain.ORCID 0000-0003-2130-8701
Carmen Díaz-BataneroDepartment of Experimental and Clinical Psychology, University of Huelva, 21071 Huelva, Spain.ORCID 0000-0003-3392-4683
Fermin Fernandez-CalderonDepartment of Experimental and Clinical Psychology, University of Huelva, 21071 Huelva, Spain.
Óscar M LozanoDepartment of Experimental and Clinical Psychology, University of Huelva, 21071 Huelva, Spain.ORCID 0000-0003-2722-6563
Universidad de Huelva · ES

Funding

Ministerio de Ciencia, Innovación y Universidades FPU18/00490
6 · The paper itself

Abstract

backgroundThe impact of dual pathology on treatment outcomes is unclear, with the literature reporting both favorable and unfavorable evidence. The main aim of this study was to determine how dual pathology affects treatment outcomes using real world data obtained from inpatients that began treatment in therapeutic communities.

methodThe data of 2458 inpatients were used. Clinical information was obtained from electronic medical records. Reliability of diagnosis was checked and revealed a mean kappa value of 0.88.

resultsOf the sample, 41.8% were discharged after achieving the therapeutic objectives. Patients diagnosed with Cluster B personality disorders were found to have a higher risk of dropping out of treatment (HR = 1.320; z = 2.61;

conclusionsPersonality traits exhibited by Cluster B patients can interfere with treatment in therapeutic communities. There is a need to develop specific interventions for these inpatient groups, which could be implemented in therapeutic communities.

Indexed as

comorbid mental disordersdropoutdrug abusedual pathologyoutcomestherapeutic community

Identifiers

PMID34200750
PMCPMC8230360
OpenAlexW3166049993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.